Migraine Formula Tablet, Film Coated
NDC Package 79481-0211-0

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

Migraine Formula (acetaminophen, aspirin, caffeine) tablets is •do not use more than directed•adults: take 2 geltabs with a glass of water•if symptoms persist or worsen, ask your doctor•do not take more than 2 geltabs in 24 hours, unless directed by a doctor•under 18 years of age: as a doctor. This formulation utilizes a tablet, film coated delivery system. Marketed by Meijer, Inc., this product is identified by NDC 79481-0211 and is authorized under FDA application ANDA075794.

Identification & Billing

NDC Package Code
79481-0211-0
Package Description
1 BOTTLE in 1 CARTON / 80 TABLET, FILM COATED in 1 BOTTLE (79481-0211-1)
Product Code
11-Digit Billing Format
79481021100
RxNorm Crosswalk
  • RxCUI: 308297 - acetaminophen 250 MG / aspirin 250 MG / caffeine 65 MG Oral Tablet
  • RxCUI: 308297 - APAP 250 MG / ASA 250 MG / caffeine 65 MG Oral Tablet

Clinical Specifications

Proprietary Name
Migraine Formula
Non-Proprietary Name
Acetaminophen, Aspirin, Caffeine
Substance Name
Acetaminophen; Aspirin; Caffeine
Dosage Form
Tablet, Film Coated - A solid dosage form that contains medicinal substances with or without suitable diluents and is coated with a thin layer of a water-insoluble or water-soluble polymer.
Administration Route
Oral - Administration to or by way of the mouth.
Usage Information
•do not use more than directed•adults: take 2 geltabs with a glass of water•if symptoms persist or worsen, ask your doctor•do not take more than 2 geltabs in 24 hours, unless directed by a doctor•under 18 years of age: as a doctor

Regulatory & Marketing

Labeler Name
Meijer, Inc.
Product Type
Human Otc Drug
FDA Application #
ANDA075794
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
03-05-2026
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 79481-0211-0 identifies a specific commercial package of 1 bottle in 1 carton / 80 tablet, film coated in 1 bottle (79481-0211-1) of Migraine Formula, a human over the counter drug labeled by Meijer, Inc.. This tablet, film coated is formulated for oral use and contains acetaminophen; aspirin; caffeine as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Meijer, Inc. on March 05, 2026. The current certification is valid through December 31, 2027.

How is this Meijer, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 79481021100. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
79481-0211-0
11-Digit CMS (5-4-2)
79481-0211-00

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.